{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:50:19Z","timestamp":1772121019419,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1158818N"],"award-info":[{"award-number":["1158818N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jamda.2020.06.018","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:42:12Z","timestamp":1592192532000},"page":"909-914.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents"],"prefix":"10.1016","volume":"21","author":[{"given":"Anton","family":"De Spiegeleer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoon","family":"Bronselaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Byttebier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"De Tr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Belmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Wynendaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Van De Wiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Vandaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diemer","family":"Van Dijck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Bean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fedson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6794-3108","authenticated-orcid":false,"given":"Bart","family":"De Spiegeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2020.06.018_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jamda.2020.06.018_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jamda.2020.06.018_bib3","doi-asserted-by":"crossref","first-page":"E438","DOI":"10.1097\/PCC.0b013e3182a55735","article-title":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome","volume":"14","author":"Wosten-van Asperen","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jamda.2020.06.018_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist","volume":"225","author":"Woesten-van Asperen","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jamda.2020.06.018_bib5","doi-asserted-by":"crossref","first-page":"L1026","DOI":"10.1152\/ajplung.00354.2004","article-title":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury","volume":"288","author":"Jacobson","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jamda.2020.06.018_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21037\/atm.2016.11.03","article-title":"Treating the host response to emerging virus diseases: Lessons learned from sepsis, pneumonia, influenza and Ebola","volume":"4","author":"Fedson","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jamda.2020.06.018_bib7","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jamda.2020.06.018_bib8","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","author":"McGonagle","year":"2020","journal-title":"Lancet Rheum"},{"key":"10.1016\/j.jamda.2020.06.018_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemostas"},{"key":"10.1016\/j.jamda.2020.06.018_bib10","article-title":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2","author":"Yin","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jamda.2020.06.018_bib11","series-title":"Kinins and cytokines in COVID-19: A comprehensive pathophysiological approach, Preprints","author":"van de Veerdonk","year":"2020"},{"key":"10.1016\/j.jamda.2020.06.018_bib12","doi-asserted-by":"crossref","first-page":"e13130","DOI":"10.1111\/eci.13130","article-title":"A\u00a0revised systematic review and meta-analysis on the effect of statins on D-dimer levels","volume":"49","author":"Schol-Gelok","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jamda.2020.06.018_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.diabres.2017.11.004","article-title":"Evaluation of protein C and protein S levels in patients with diabetes mellitus receiving therapy with statins and ACE inhibitors or angiotensin II receptor blockers","volume":"135","author":"Aktas","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jamda.2020.06.018_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jamda.2020.06.018_bib15","doi-asserted-by":"crossref","first-page":"e00398","DOI":"10.1128\/mBio.00398-20","article-title":"Hiding in plain sight: An approach to treating patients with severe COVID-19 infection","volume":"11","author":"Fedson","year":"2020","journal-title":"Mbio"},{"key":"10.1016\/j.jamda.2020.06.018_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: In silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jamda.2020.06.018_bib17","first-page":"OA3329","article-title":"Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia","volume":"48","author":"Mortensen","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jamda.2020.06.018_bib18","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jamda.2020.06.018_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jamda.2020.06.018_bib20","series-title":"Treatment with ACE-inhibitors is associated with less severe SARS-Covid-19 infection in a multi-site UK acute Hospital Trust","author":"Bean","year":"2020"},{"key":"10.1016\/j.jamda.2020.06.018_bib21","series-title":"Angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors usage is associated with improved inflammatory status and clinical outcomes in COVID-19 patients with hypertension, medRxiv","author":"Guang","year":"2020"},{"key":"10.1016\/j.jamda.2020.06.018_bib22","series-title":"Anti-hypertensive angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients, medRxiv","author":"Yingxia","year":"2020"},{"key":"10.1016\/j.jamda.2020.06.018_bib23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jamda.2020.06.018_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/0145561320920762","article-title":"Clinical presentation of COVID-19: A systematic review focusing on upper airway symptoms","author":"Lovato","year":"2020","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jamda.2020.06.018_bib27","first-page":"187","article-title":"Firth logistic regression for rare variant association tests","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.jamda.2020.06.018_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum-likelihood-estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.jamda.2020.06.018_bib29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa2005412","article-title":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington","volume":"382","author":"McMichael","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2020.06.018_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.06.018_bib31","doi-asserted-by":"crossref","first-page":"m1727","DOI":"10.1136\/bmj.m1727","article-title":"Covid-19: Deaths in care home deaths in England and Wales rise sharply","volume":"369","author":"O'Dowd","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.06.018_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/089686080902900514","article-title":"Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and outcome of COVID-19: A systematic review and meta-analysis","volume":"29","author":"Abdulhak","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jamda.2020.06.018_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jamda.2020.06.018_bib34","author":"Cox"},{"key":"10.1016\/j.jamda.2020.06.018_bib35","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2020.06.018_bib36","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A\u00a0trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2020.06.018_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A\u00a0systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jamda.2020.06.018_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J\u00a0Clin Invest"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020305247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020305247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:20:26Z","timestamp":1761506426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861020305247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1525861020305247"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2020.06.018","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.11.20096347","asserted-by":"object"}]},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2020.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}